RhumbLine Advisers’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.9M | Sell |
|
|||||
|
2025
Q2 | $9.56M | Buy |
|
|||||
|
2025
Q1 | $7.84M | Buy |
|
|||||
|
2024
Q4 | $6.25M | Sell |
|
|||||
|
2024
Q3 | $7.39M | Buy |
|
|||||
|
2024
Q2 | $2.94M | Sell |
|
|||||
|
2024
Q1 | $2.46M | Buy |
|
|||||
|
2023
Q4 | $1.91M | Buy |
|
|||||
|
2023
Q3 | $1.38M | Buy |
|
|||||
|
2023
Q2 | $2.15M | Buy |
|
|||||
|
2023
Q1 | $1.72M | Buy |
|
|||||
|
2022
Q4 | $776K | Buy |
|
|||||
|
2022
Q3 | $594K | Buy |
|
|||||
|
2022
Q2 | $527K | Buy |
|
|||||
|
2022
Q1 | $1.1M | Buy |
|
|||||
|
2021
Q4 | $1.5M | Buy |
|
|||||
|
2021
Q3 | $757K | Buy |
|
|||||
|
2021
Q2 | $1.83M | Buy |
|
|||||
|
2021
Q1 | $860K | Sell |
|
|||||
|
2020
Q4 | $680K | Buy |
|
|||||
|
2020
Q3 | $576K | Sell |
|
|||||
|
2020
Q2 | $524K | Buy |
|
|||||
|
2020
Q1 | $118K | Buy |
|
|||||
|
2019
Q4 | $115K | Buy |
|
|||||
|
2019
Q3 | $187K | Buy |
|
|||||
|
2019
Q2 | $156K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $88K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $178K | Buy |
|
|||||
|
2017
Q2 | $114K | Buy |
|